Clinical Trials Directory

Trials / Unknown

UnknownNCT05182723

Evaluation of the Effectiveness of Extracorporeal Methods for Removing Mediators of Systemic Inflammation

Evaluation of the Effectiveness of Extracorporeal Methods for Removing Mediators of Systemic Inflammation in Patient With Multiple Organ Dysfunction Syndrome After Heart and Aortic Surgery

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Petrovsky National Research Centre of Surgery · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the effectiveness and the safety of extracorporeal methods for removing mediators of systemic inflammation in patients with multiple organ dysfunction syndrome after heart and aorta surgery.

Detailed description

After being informed about the study and potential risk, all patients with multiple organ dysfunction syndrome after heart and aorta surgery with indications for extracorporeal removal of inflammatory mediators, giving written informed consent will be included in the study. Patients will be randomized 1:1 ratio to 1. hemoperfusion cartridge for cytokine sorption in combination with an oXiris membrane and 2. oXiris membrane.

Conditions

Interventions

TypeNameDescription
PROCEDURErenal replacement therapyExtracorporeal Methods for Removing Mediators of Systemic Inflammation

Timeline

Start date
2021-11-25
Primary completion
2024-11-30
Completion
2025-05-31
First posted
2022-01-10
Last updated
2022-02-03

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT05182723. Inclusion in this directory is not an endorsement.